{
    "organizations": [],
    "uuid": "36d0523450404d01e31141f36372f1f5adfeb202",
    "author": "Preetika Rana",
    "url": "https://www.wsj.com/articles/takeda-pharmaceutical-agrees-to-buy-shire-in-62-billion-deal-1525761607",
    "ord_in_thread": 0,
    "title": "Takeda Wins Battle for Shire With $62 Billion Deal",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Takeda Pharmaceutical Co. on Tuesday reached an agreement to buy Shire PLC, capping a monthslong battle for control of the European drugmaker and marking the biggest-ever overseas acquisition by a Japanese company.\nShire’s board agreed Takeda could buy it at £49.01 or $66.21 a share—$30.33 in cash and 0.839 of a Takeda share for each Shire share—in a deal that valued the target at $62 billion. Both companies still need shareholders to sign off.\n... ",
    "published": "2018-05-08T10:43:00.000+03:00",
    "crawled": "2018-05-08T11:09:55.039+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "takeda",
        "pharmaceutical",
        "tuesday",
        "reached",
        "agreement",
        "buy",
        "shire",
        "plc",
        "capping",
        "monthslong",
        "battle",
        "control",
        "european",
        "drugmaker",
        "marking",
        "overseas",
        "acquisition",
        "japanese",
        "company",
        "shire",
        "board",
        "agreed",
        "takeda",
        "could",
        "buy",
        "cash",
        "takeda",
        "share",
        "shire",
        "deal",
        "valued",
        "target",
        "billion",
        "company",
        "still",
        "need",
        "shareholder",
        "sign"
    ]
}